|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/85 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 2905338 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14198318.9 |
| Date of filing the European patent application | 2011-06-22 | |
| (97) | Date of publication of the European application | 2015-08-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-02 |
| (46) | Date of publication of the claims translation | 2017-12-27 |
| (30) | Number | Date | Country code |
| 357314 P | 2010-06-22 | US | |
| 357317 P | 2010-06-22 | US |
| (72) |
Murphy, Andrew J., US
Stevens, Sean, US
Gurer, Cagan, US
Macdonald, Lynn, US
Hosiawa, Karolina A., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Transgeninė pelė su modifikuotu endogeniniu lambda imunoglobulino lokusu |
| Trangenic mice with a modified endogenous lambda immunoglobulin locus |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 15 | 289.00 EUR |
| 2026-06-22 |